FOLFIRI regimen
|
WikiDoc Resources for FOLFIRI regimen |
|
Articles |
|---|
|
Most recent articles on FOLFIRI regimen Most cited articles on FOLFIRI regimen |
|
Media |
|
Powerpoint slides on FOLFIRI regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on FOLFIRI regimen at Clinical Trials.gov Trial results on FOLFIRI regimen Clinical Trials on FOLFIRI regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on FOLFIRI regimen NICE Guidance on FOLFIRI regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on FOLFIRI regimen Discussion groups on FOLFIRI regimen Patient Handouts on FOLFIRI regimen Directions to Hospitals Treating FOLFIRI regimen Risk calculators and risk factors for FOLFIRI regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for FOLFIRI regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:FOLFIRI; FOLFIRI Regimen; FOLFIRI regimen; Folinic Acid-Fluorouracil-Irinotecan Regimen
Overview
FOLFIRI regimen refers to a chemotherapy regimen consisting of leucovorin calcium (calcium folinate), 5-fluorouracil, and irinotecan used in the treatment of advanced-stage and metastatic colorectal cancer.[1][2]
Regimen
FOLLeucovorin calcium (Folinic acid)
FI5-Fluorouracil
RIIrinotecan
Indications
References
- ↑ "NCI Thesaurus".
- ↑ 2.0 2.1 André T, Louvet C, Maindrault-Goebel F, Couteau C, Mabro M, Lotz JP; et al. (1999). "CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR". Eur J Cancer. 35 (9): 1343–7. PMID 10658525.